Delivery Order SPE2DB20D2104-SPE2DB25FMMAA
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Boostrix TDAP vaccine syringes (0.5mL) to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,063.64 and an ultimate completion date of December 13, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of Boostrix TDAP vaccine syringes to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 24, 2024 with a ceiling value of $2,530.80. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2025 with a ceiling value of $49,910.07. The contract has a firm fixed price and an ultimate completion date of February 25, 2025. The contract is a delivery order and is not associated with a set-aside...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $4,163.57. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,583.80, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is April 16, 2024. The contract is not designated as a set-aside and was...
This federal contract award is for the delivery of Boostrix TDAP vaccine syringes (0.5 ml) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $23,280.00 and a completion date of January 18, 2023. The contract is not associated with a set-aside program and was awarded through full and open competition. Amerisourcebergen Drug...
The federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency. The firm fixed-price contract has a ceiling value of $5,597.04 and an ultimate completion date of May 19, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp also holds a...
This federal contract award is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML by the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 10, 2025, with a ceiling value of $29,581.89 and a period of performance through March 11, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside...
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGEs, 0.5ML in quantity, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 3, 2025 for a ceiling value of $1,330.50. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,557.75 and an ultimate completion date of October 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...